Dihydroartemisinin

Dihydroartemisinin (DHA) is a drug used in the treatment of malaria. Dihydroartemisinin is a semi-synthetic derivative of artemisinin, a natural product of the Chinese herb Artemisia annua, also known as sweet wormwood. DHA is the active metabolite of all artemisinin compounds (artemisinin, artesunate, artemether, etc.) and is also available as a drug in itself.

Pharmacology

Dihydroartemisinin is a prodrug of the biologically active metabolite dihydroartemisinin. It is activated by serum esterases to dihydroartemisinin, which is thought to interact with heme to cause oxidative damage to the parasite.

Clinical use

Dihydroartemisinin is used primarily as a treatment for malaria, specifically for Plasmodium falciparum malaria. It is often combined with piperaquine in a fixed-dose combination for the treatment of uncomplicated falciparum malaria. This combination is known as dihydroartemisinin/piperaquine.

Side effects

The most common side effects of dihydroartemisinin are nausea, vomiting, and anorexia. Less common side effects include dizziness, headache, palpitations, and abdominal pain.

Resistance

Resistance to dihydroartemisinin has been reported in Southeast Asia. This resistance is associated with mutations in the kelch13 gene of the malaria parasite.

See also

• Artemisinin
• Artemisinin-based combination therapy
• Malaria treatment

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian